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Background: The human papillomavirus (HPV) prevalence in males has been reported to be between 3.6% and
84%, depending specially on the socioeconomic status. HPV infection has been related as a risk factor for penile
cancer. This is a rare tumor, and other risk factors include lack of personal hygiene and men who have not
undergone circumcision. Penile cancer is less than 1% of cancers in men in the United States, however, is much
more common in some parts of Asia, Africa, and South America, where it accounts for up to 10% of cancers in
men. This study aimed to determine the prevalence of HPV-DNA in penile cancers in São Luís, Brazil and to correlate
the virus presence to histopathological factors.
Methods: Tumor paraffin samples of 76 patients with penile carcinoma were tested in order to establish the
prevalence and distribution of genotypic HPV using PCR/Nested and automated sequencing. To evaluate the
association between HPV types and other clinical and morphological variables, a nonparametric ANOVA was
performed using a Kruskal Wallis test, and statistical significance was determined to a value of p < 0.05.
Results: The average age of patients at the time of diagnosis was 66 years ± 17.10. Regarding location, 65.79% of
the tumors were located in the glans, and the most common types were vegetative (34.21%) and squamous
(98.68%). Most of the lesions ranged in size from 2.1 to 5.0 cm, presenting Jackson I stage and Broders II degree. It
was observed that 32 patients had at least one invaded and/or infiltrated structure. Lymph node involvement was
observed in 19.76% of the patients, and 21.05% showed an inflammatory process. In the molecular evaluation, HPV
infection was observed in 63.15% of the lesions, and the most common type was HPV 16.
Conclusions: From the statistical analysis, it can be verified that the variables were not associated with infection by
the HPV virus. Although penile cancer can result from various risk factors that act in synergy, an HPV virus infection
is important for the development of such neoplasm.
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The human papillomavirus (HPV) is a DNA-virus from
the Papoviridae family - genre Papillomavirus, with more
than 100 types currently recognized, 20 of which can infect
the genital tract; the man is the main disseminator [1,2].
Penile infection by HPV may be clinical, subclinical or
latent. In clinical presentation, the diagnosis is simpler,
because it is determined from a good clinical examin-
ation to uncover existing lesions. In subclinical and la-
tent forms, other methods, such as peniscopy, are
necessary to aid in detection, as it is not possible to de-
tect changes (i.e., diagnosis) with the naked eye. In men,
there is a higher frequency of the subclinical form [2].
Penile cancer mainly affects men over 50 years old,
but approximately 19% of patients are 40 years of age or
younger, and 7% are below the age of 30 [3]. The major
risk factors of the disease are associated with hygiene,
phimosis, smegma retention, inflammation process, and
HPV infection [4].
The prevalence of the virus in males has been reported
to be between 3.6% and 84%, depending on socioeconomic
status [5,6]. Penile cancer represents 0.4% to 0.6% of all
malignant tumors in developed countries, such as the
United States and European countries, and more than
10% of all malignant tumors in developing countries, such
as those in Asia, Africa and South America [3,4].
According to Nardi et al. [7] the highest incidence rates
of penile carcinoma were found in Maranhão. Maranhão
is a city situated in the Northeast of Brazil. Favorito et al.
[8] observed a predominance of reports of penile cancer
in the North and Northeast (53.02%), which are regions
with lower human development indexes. The understand-
ing of HPV prevalence and knowledge of the viral subtype
distribution constitute important epidemiological informa-
tion that can assist the development of local or regional
public policies to prevent HPV and of new vaccines.
The aims of this study were to detect and perform
HPV genotyping in biological specimens of penile tu-
mors and to determine the existing associations between
viral presence and histopathological clinical aspects.
Methods
Enrollment
This was a retrospective study performed in paraffined
penile tumors collected at two public reference hospi-
tals in Maranhão. A total of 76 samples were included
in the study from patients diagnosed with penile can-
cer between the years 2001 and 2011. Patient informa-
tion as well as the histopathological characteristics of
the tumors obtained from medical records. As the
samples consisted in paraffined tumours, there was no
written informed consent from the patients. The pa-
tient identity was not disclosed in this research. This work
was approved by the Ethics in Research Committee of theUniversity Hospital of the Federal University of Maranhão
(HU/UFMA).
Inclusion criteria
Paraffin blocks and histological slides of penile tumors
as a result of biopsy or surgical treatment, with or with-
out lymphadenectomy at any follow–up in the archives
of the Pathology Services.
Exclusion criteria
Histological slides and/or paraffined blocks not found in
the archives of the Pathology Services of referral hospi-
tals and reports did not provide complete information.
HPV analysis
The samples were reviewed by the pathologist, and blocks
with tumor representativeness (over 50% of the total area
of the fragment) were selected. After microtomy, sections
suffered a process of deparaffinization. The sections were
stored at 4°C, awaiting DNA extraction.
The extraction of the genomic DNA from the samples
was performed using the QIAamp DNA FFPE Tissue
Purification Kit (QIAGEN®) according to the extraction
protocol suggested by the manufacturer.
The Nested PCR reactions were performed by using
primers PGMY09 and PGMY11 for the first round, and
primers GP + 5 and GP + 6 for the second round [9].
The sequencing reactions were performed in the La-
boratory of Genetics of the National Cancer Institute
(INCA) with ET Dye Terminator Cycle Sequencing kit
(GE Healthcare, UK) according to the manufacturer’s
suggested protocol.
Statistical analysis
All data were collected and prospectively input in an
EpiInfo 3.4.3 and Microsoft Office 2007® were used for
the statistical analysis.
To evaluate the association between HPV types and
other clinical and morphological variables, a nonpara-
metric ANOVA was performed using the Kruskal Wallis
test with a statistical significance level of 5% probability
(p < 0.05).
Results and discussion
Tumor biopsies of penile cancer were evaluated in 76
patients aged 26 to 97 years with a mean of 60.7 years
and standard deviation of ±17.10, presenting a higher
prevalence in the over 66 age group. The clinical repre-
sentation and pathologic characteristics distribution is
shown on Table 1.
These results correspond with those obtained in the
literature [10-14]. The average age of the patients at
diagnosis predominates in advanced age (>50 years),
which suggests that men seek health services very late in
Table 1 Age, clinical presentation and pathologic
characteristics from 76 patients diagnosed with penile
cancer
Age at diagnosis N %






Glans add other regions 50 65.79
Foreskin 08 10.53
Corpus 03 3.95




Ulceration and Vegetating 17 22.37
Nodule and Vegetating 01 1.32
Non evaluable 16 21.05





Non evaluable 02 2.63
Staging of Jackson 1966
Stage I 33 43.42
Stage II 16 21.05
Stage III 11 14.48
Stage IV 16 21.05
Broders’ Classification
Grade I 26 34.21
Grade II 36 47.37
Grade III 06 7.89









Urethra and Stroma 01 1.32
Absent 44 57.89
Table 1 Age, clinical presentation and pathologic
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smaller percentages [7].
Regarding the location of the lesions, the glans, in an
isolated form or associated with other regions, was the
most affected structure as in the research by Delgado
et al. [10], Wanick et al. [11] and Favorito et al. [8].
Studies have shown that the lesions on the glans are
directly linked to poor hygiene. This occurs due to the
formation of a mass, called smegma, followed by likely
irritation of the site and onset of injury, facilitating vari-
ous infections and future neoplasia if left untreated [10].
Regarding the clinical morphology, the predominantly
found lesion was the vegetating type followed by ulcer-
ation. The occurrence of both types of lesions in the
same patient was observed in 22.37% of the cases. In a
study performed in Spain, researchers observed that the
vegetative lesion was also more present, in 66% of the
cases [12]. On the other hand, in another research con-
ducted in Rio de Janeiro [10], a larger number of lesions
was detected in the form of ulcerations, nearly 55.88% of
the studied cases.
The dimensions of the lesions were similar to those
observed in the Wanick et al. results [10], with a larger
number of cases: 52.63% of the cases, with size between
2.1 and 5.0 cm.
Unlike other studies, the moderately differentiated tu-
mors (grade II) identified in this work, according toTable 2 HPV prevalence and distribution according to
oncogenic risk in 76 patients diagnosed with penile
cancer
HPV n %
HPV + 48 63.15
HPV - 28 36.85
Oncogenic risk
High risk 17 35.42
Low risk 6 12.50
Indeterminate 25 52.08
Table 3 Association of clinical presentation and
pathologic characteristics data with HPV infection
patients with penile cancer
HPV + HPV - p-values*
Lesion area 0.543
Glans add other regions 31 19
Foreskin 4 4
Corpus 2 1




Ulceration and Vegetating 09 07
Nodule and Vegetating 01 00
Non evaluable 10 06








Staging of Jackson 1966 0.381
Stage I 21 12
Stage II 07 09
Stage III 07 04
Stage IV 13 03
Broders’ Classification 0.352
Grade I 20 06
Grade II 21 15
Grade III 02 04









Urethra and Stroma 1 0
Absent 26 18
Table 3 Association of clinical presentation and
pathologic characteristics data with HPV infection
patients with penile cancer (Continued)









*Estimated by univariate logistic regression analysis;
P = Statistical significance; 95% CI = 95% confidence interval.
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et al. [13] identified a greater number of cases classified
as well differentiated (grade I). However, Scheiner et al.
[14] observed higher incidence of grade III (undifferen-
tiated) tumors, which can be explained by the greater
presence of stage III and IV patients.
The findings indicated that invasion was present in
23.68%, and infiltration occurred in at least one of the
structures, with the highest prevalence in the corpus
cavernosum. Koifman et al. [15] reported the presence
of invasion of the spongiosum or cavernous corpus in
41.3% of the patients.
Regarding lymph node involvement, a percentage of
19.73% was observed. According to Sacoto et al. [12],
patients with more advanced disease and positive lymph
nodes at the time of diagnosis had a worse survival rate
than those with localized stages.
The DNA of the HPV was detected in 63.15% (48/76)
of the samples. The oncogenic risk distribution is shown
on Table 2. This percentage is within the range reported
in the literature, which shows that the rate of HPV infec-
tion in penile malignant tumors may vary from 20 to
over 75% of cases [16]. According to a systematic review
of the prevalence of HPV in invasive tumors of the
penis, 48% of the samples presented HPV infection [17].
A Belgian study by D’Hauwers et al. [18], which had the
same number of patients as in this study, revealed that
70.9% of the tumors had the HPV virus. However, a sur-
vey conducted in Vietnam demonstrated that only 23%
of tumors had HPV infection [19]. A study conducted in
Brazil showed that 75% of invasive penile tumors were
infected by HPV [14]. These variations may be due to
different techniques used for viral detection, regional
differences or histological type of the analyzed tumor.
In our study, among the high-risk viral types present
were the 16, 18, 45 and 69 types. The HPV of type 11
was the only low oncogenic risk found. Type 16 was the
most prevalent, found in 10 cases, followed by type 11 of
de Sousa et al. BMC Urology  (2015) 15:13 Page 5 of 6low risk with 6 cases, type 18 with 4 cases, type 69 with
two cases and type 45 with 1 case. The automated se-
quencing technique was not effective for viral genotyp-
ing, because in more than 50% of the samples it was not
possible to achieve. This may be due to the presence of
co-infections in these samples, which prevents the device
from detecting the virus, as described by Gharizadeh et al.
(2005) and Verteramo et al. (2009) [20,21]. The most com-
mon viral type found in this study was HPV 16, high-risk
type. This virus type was also the most found in other
studies such as those developed by Do et al. [19] (89%),
D’Hauwers et al. [18] (48.3%) and Heidman et al. [16]
in (52%).
As shown in Table 3, no association was found (p <
0.05) between infection with HPV virus and clinical and
histopathological and clinical variables, as was the case
in the research by Do et al. [19], Fonseca et al. [22] and
Scheiner et al. [14].
Infections by HPV are strongly associated with the de-
velopment of penile cancer; however, the role of viruses
in the etiology is not very clear [21]. Although the eti-
ology is still unknown, approximately 40% of all penile
tumors are related to HPV infection [22].
Conclusion
HPV DNA was found in 48 of the 76 analyzed samples
(63,15%). The high-risk type HPV 16 was observed in
21.28% (10/48) of the lesions followed by low-risk type
HPV 11 in 12.76% (6/48) and high-risk types HPV 18 in
8.51% (4/48), HPV 69 in 4.25% (2/48) and HPV 45 in
2.13% (1/48). In 51.06% of the cases, genotyping was in-
determinate, suggestive of co-infection.
The average age of the patients in the study was
60.6 years old. Prevalent lesions were larger than 2 cm, in
the glans region, in general vegetating, and with Broder’s
grade II (moderately differentiated). The clinical and histo-
pathological variables did not tend to have an association
with infection by the HPV virus.
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